Such abrogation of insulin action or insulin resistance is a key component in the development of Non-Alcoholic Fatty Liver Disease (NAFLD) (Ota et al. 2007; Gaggini et al. 2013, Kitade et al. 2017). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.